Stay updated on Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.

Latest updates to the Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange Detected- The page history now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates a minor version update to the study record history interface rather than substantive data changes.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedA new revision entry (v3.6.3) was added to the Record History and the older entry (v3.6.0) was removed, updating the page's version history.SummaryDifference0.1%

- Check51 days agoChange DetectedThe record now indicates that the trial is no longer recruiting participants, and it adds the latest revision (v3.6.0) while removing the previous revision (v3.5.5) from the history.SummaryDifference0.2%

- Check58 days agoChange DetectedA new revision entry v3.5.5 was added to the history, and the previous entry v3.5.4 was removed from the visible list, reflecting an update to the record's revision history.SummaryDifference0.1%

- Check80 days agoChange DetectedThe history page now shows a new release note entry 'Revision: v3.5.4' replacing the previous 'Revision: v3.5.3', indicating a software update to the ClinicalTrials.gov interface rather than a change to the study record.SummaryDifference0.1%

- Check101 days agoChange DetectedThe page header/footer shows an update to the interface version from v3.5.2 to v3.5.3, indicating a software/display release rather than a change to the trial record itself.SummaryDifference0.1%

Stay in the know with updates to Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.